Charlottesville-based Phthisis Diagnostics, LLC was one of the emerging companies selected to give a presentation to the attending investors. Crystal Icenhour, PhD, President & Director of Research said "the current economy presents a challenge when it comes to raising funds. A conference like the Mid-Atlantic Bio provides a great opportunity to meet potential investors, develop relationships with potential strategic partners, and to learn about other emerging technologies."
Virginia investor and member of University of Virginia's Board of Visitor Randal J. Kirk spoke during the plenary session about the next ten years of research, and access to funding sources in a tight capital market.
Next year's Mid-Atlantic BioTech Conference is scheduled for Oct 25, 2010 in Bethesda.



